Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

2.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.7K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
T Cell Types and Functions01:24

T Cell Types and Functions

1.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

2.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.9K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.3K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.8K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxic Ischemic Encephalopathy.

Neuroimaging clinics of North America·2026
Same author

Learning Curve for Transbronchial Lung Cryobiopsy in Interstitial Lung Disease Diagnosis: A Multicenter Experience.

Respiration; international review of thoracic diseases·2026
Same author

Pleural Fluid Outperforms Plasma for Detection of Clinically Relevant Mutations in Lung Cancer-Associated Malignant Pleural Effusion.

Archivos de bronconeumologia·2026
Same author

Diagnostic performance and safety of image-guided pleural biopsy and medical thoracoscopy for undiagnosed exudative pleural effusion: a systematic review and network meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Predictive Value of Air Bubble and Meniscus Signs on Routine Trauma Head CT for Nondisplaced Temporal Bone Fractures.

AJNR. American journal of neuroradiology·2026
Same author

Beyond miRNAs: exploratory profiling of PIWI-interacting RNAs and small nucleolar RNAs in non-small cell lung cancer-related malignant pleural effusions.

Translational lung cancer research·2026

Related Experiment Video

Updated: Dec 13, 2025

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

1.4K

Platelet factor 4 regulates T cell effector functions in malignant pleural effusions.

Maria Mulet1, Carlos Zamora1, José M Porcel2

  • 1Department Immunology, Institut Recerca Hospital de La Santa Creu i Sant Pau, Barcelona, Spain.

Cancer Letters
|July 30, 2020
PubMed
Summary

Malignant pleural effusion in lung adenocarcinoma involves higher levels of Platelet Factor 4 (PF4), which impairs T cell function. This suggests PF4 contributes to tumor progression by hindering the immune response.

Keywords:
ImmunosuppressionLung cancerMPEPF4Platelet-derived soluble factorsT lymphocytes

More Related Videos

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.1K
Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
08:02

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on: July 27, 2022

2.8K

Related Experiment Videos

Last Updated: Dec 13, 2025

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

1.4K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.1K
Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
08:02

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on: July 27, 2022

2.8K

Area of Science:

  • Immunology
  • Oncology
  • Pulmonology

Background:

  • Malignant pleural effusion (MPE) is a critical complication of advanced lung adenocarcinoma (LAC).
  • Understanding the tumor immune microenvironment in MPE is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of immunomodulatory factors in the MPE of LAC patients.
  • To assess the impact of MPE on T cell function and correlate findings with prognosis.

Main Methods:

  • ELISA was used to quantify immunomodulatory factors in MPE from LAC and heart failure (HF) patients.
  • Flow cytometry analyzed T cell proliferation, cytotoxicity, and cytokine production when stimulated with pleural fluids.
  • Correlation analyses examined relationships between factors and T cell function, and prognosis.

Main Results:

  • MPE from LAC showed elevated levels of Platelet Factor 4 (PF4), VEGF, TGF-β, and P-selectin compared to HF.
  • LAC pleural fluids suppressed T lymphocyte proliferation, cytotoxicity, and IL-17 production.
  • PF4 levels inversely correlated with T cell function and were associated with poor prognosis in MPE.

Conclusions:

  • Elevated PF4 in MPE contributes to tumor progression by inducing T cell dysfunction.
  • Targeting PF4 may represent a therapeutic strategy for managing lung adenocarcinoma with MPE.